Precision BioSciences (DTIL) Competitors $4.50 -0.11 (-2.39%) Closing price 04:00 PM EasternExtended Trading$4.64 +0.14 (+3.00%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DTIL vs. ANNX, VYGR, LYEL, TKNO, TNXP, SGMT, ACIU, ACRS, HUMA, and AVTEShould you be buying Precision BioSciences stock or one of its competitors? The main competitors of Precision BioSciences include Annexon (ANNX), Voyager Therapeutics (VYGR), Lyell Immunopharma (LYEL), Alpha Teknova (TKNO), Tonix Pharmaceuticals (TNXP), Sagimet Biosciences (SGMT), AC Immune (ACIU), Aclaris Therapeutics (ACRS), Humacyte (HUMA), and Aerovate Therapeutics (AVTE). These companies are all part of the "pharmaceutical products" industry. Precision BioSciences vs. Its Competitors Annexon Voyager Therapeutics Lyell Immunopharma Alpha Teknova Tonix Pharmaceuticals Sagimet Biosciences AC Immune Aclaris Therapeutics Humacyte Aerovate Therapeutics Precision BioSciences (NASDAQ:DTIL) and Annexon (NASDAQ:ANNX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings. Which has more risk & volatility, DTIL or ANNX? Precision BioSciences has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, Annexon has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Do institutionals and insiders have more ownership in DTIL or ANNX? 38.0% of Precision BioSciences shares are owned by institutional investors. 4.0% of Precision BioSciences shares are owned by insiders. Comparatively, 12.7% of Annexon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is DTIL or ANNX more profitable? Annexon has a net margin of 0.00% compared to Precision BioSciences' net margin of -6,205.79%. Annexon's return on equity of -70.04% beat Precision BioSciences' return on equity.Company Net Margins Return on Equity Return on Assets Precision BioSciences-6,205.79% -176.47% -69.05% Annexon N/A -70.04%-57.67% Does the media favor DTIL or ANNX? In the previous week, Precision BioSciences had 1 more articles in the media than Annexon. MarketBeat recorded 2 mentions for Precision BioSciences and 1 mentions for Annexon. Annexon's average media sentiment score of 1.89 beat Precision BioSciences' score of 0.48 indicating that Annexon is being referred to more favorably in the news media. Company Overall Sentiment Precision BioSciences Neutral Annexon Very Positive Do analysts recommend DTIL or ANNX? Precision BioSciences presently has a consensus target price of $47.00, indicating a potential upside of 944.44%. Annexon has a consensus target price of $12.50, indicating a potential upside of 402.01%. Given Precision BioSciences' stronger consensus rating and higher probable upside, equities analysts clearly believe Precision BioSciences is more favorable than Annexon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precision BioSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Annexon 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has stronger earnings & valuation, DTIL or ANNX? Precision BioSciences has higher revenue and earnings than Annexon. Annexon is trading at a lower price-to-earnings ratio than Precision BioSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrecision BioSciences$68.70M0.77$7.17M-$8.81-0.51AnnexonN/AN/A-$138.20M-$1.29-1.93 SummaryPrecision BioSciences and Annexon tied by winning 7 of the 14 factors compared between the two stocks. Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DTIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DTIL vs. The Competition Export to ExcelMetricPrecision BioSciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$54.34M$3.11B$5.75B$10.24BDividend YieldN/A2.32%5.69%4.60%P/E RatioN/A21.3874.9326.41Price / Sales0.77224.82452.3586.56Price / CashN/A44.4425.8129.91Price / Book0.669.6413.256.28Net Income$7.17M-$53.20M$3.29B$270.38M7 Day Performance-9.46%0.44%0.47%2.70%1 Month Performance-4.46%4.26%4.60%5.99%1 Year Performance-56.31%9.43%73.42%25.94% Precision BioSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DTILPrecision BioSciences4.0981 of 5 stars$4.50-2.4%$47.00+944.4%-55.2%$54.34M$68.70M0.00200ANNXAnnexon2.6158 of 5 stars$2.21+1.8%$12.50+465.6%-66.4%$238.45MN/A-1.7160Positive NewsVYGRVoyager Therapeutics4.0291 of 5 stars$4.26+0.5%$13.25+211.0%-33.1%$235.19M$80M-2.30100News CoveragePositive NewsAnalyst ForecastGap UpLYELLyell Immunopharma2.7554 of 5 stars$13.03+7.2%$15.00+15.1%-47.9%$233.42M$60K-0.54270Positive NewsTKNOAlpha Teknova2.8212 of 5 stars$4.35-0.2%$10.00+129.9%+1.1%$233.33M$37.74M-10.36240Positive NewsTNXPTonix Pharmaceuticals3.2849 of 5 stars$25.29-4.7%$70.00+176.8%+82.5%$232.65M$9.83M-0.6450SGMTSagimet Biosciences3.3654 of 5 stars$7.03-1.1%$25.67+265.1%+81.7%$231.23M$2M-3.848News CoverageAnalyst DowngradeACIUAC Immune2.6151 of 5 stars$2.20-3.5%$10.00+354.5%-23.6%$228.94M$31.02M-3.79140Positive NewsACRSAclaris Therapeutics2.6793 of 5 stars$2.08-1.0%$8.71+319.0%+65.3%$227.50M$18.72M-1.52100News CoveragePositive NewsGap DownHUMAHumacyte3.1373 of 5 stars$1.41-1.4%$9.75+591.5%-73.9%$226.47M$1.57M-3.13150News CoveragePositive NewsAnalyst ForecastGap UpAVTEAerovate TherapeuticsN/A$7.77-0.1%N/A-88.4%$225.21MN/A-2.6020Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Annexon Alternatives Voyager Therapeutics Alternatives Lyell Immunopharma Alternatives Alpha Teknova Alternatives Tonix Pharmaceuticals Alternatives Sagimet Biosciences Alternatives AC Immune Alternatives Aclaris Therapeutics Alternatives Humacyte Alternatives Aerovate Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DTIL) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DTIL Stock Alerts